| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |